US FDA approves Novartis' Afinitor to treat adult patients with kidney tumours
The US Food and Drug Administration (FDA) has approved Novartis' drug Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumours known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require ...
Afinitor (Everolimus) Approved For Renal Angiomyolipomas By FDA
FDA Expands Everolimus Label
FDA Approves Everolimus for Renal Angiomyolipomas